Understanding artery damage in sickle cell disease
Artery biomechanics and vascular damage in sickle cell disease
This study is looking at how sickle cell disease impacts blood vessels and what role certain enzymes play in causing damage, with the hope of finding new treatments to help protect your arteries as you get older.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Institute of Technology NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10832036 on NIH RePORTER |
What this research studies
This research investigates how sickle cell disease affects the biomechanics of arteries, leading to significant vascular damage. It focuses on the role of specific enzymes, called cysteine cathepsins, that contribute to the breakdown of important structural proteins in blood vessels. By studying these mechanisms, the research aims to identify potential new therapies that could prevent or reduce arterial damage in individuals with sickle cell disease as they age. The study utilizes advanced imaging techniques and animal models to explore the relationship between these enzymes and arterial health.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have been diagnosed with sickle cell disease.
Not a fit: Patients with sickle cell disease who are under 21 years old may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve vascular health and life expectancy for patients with sickle cell disease.
How similar studies have performed: Previous research has shown promising results in understanding the role of proteases in vascular diseases, suggesting that this approach could yield valuable insights and potential breakthroughs.
Where this research is happening
Atlanta, United States
- Georgia Institute of Technology — Atlanta, United States (Active)
Researchers
- Principal investigator: Botchwey, Edward a. — Georgia Institute of Technology
- Study coordinator: Botchwey, Edward a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.